The UK Competition Authority investigates a pharmaceutical company for abuse of dominance (Essential Pharma)
On 6 October 2020, the Competition and Markets Authority ( CMA ) started an inquiry into Essential Pharma to determine whether that company abused an allegedly dominant position when announcing the withdrawal from the UK market of Priadel®, a
Access to this article is restricted to subscribers
Already Subscribed? Sign-in